Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$1.73B |
| 2 |
Ingersoll Rand
IR
|
+$1.19B |
| 3 |
Charter Communications
CHTR
|
+$1.18B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.08B |
| 5 |
Rexford Industrial Realty
REXR
|
+$905M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.89B |
| 2 |
Zoetis
ZTS
|
+$2.73B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.34B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.88B |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.67% |
| 2 | Financials | 14.61% |
| 3 | Industrials | 14.19% |
| 4 | Healthcare | 12.1% |
| 5 | Communication Services | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Netflix
NFLX
$309B
| $4.3B | 0.87% |
70,875,010
-18,023,090
| -20% | -$1.02B |
|
27
KKR & Co
KKR
$99.5B
| $4.29B | 0.87% |
42,630,272
-178,514
| -0.4% | -$16.4M |
|
28
Salesforce
CRM
$158B
| $4.25B | 0.86% |
14,116,449
+407,834
| +3% | +$118M |
|
29
Royal Caribbean
RCL
$82.4B
| $4.11B | 0.83% |
29,596,455
+286,868
| +1% | +$35.8M |
|
|
MRSH
30
Marsh
MRSH
$90.1B
| $4.11B | 0.83% |
19,952,473
-20,309
| -0.1% | -$4.05M |
|
31
Bristol-Myers Squibb
BMY
$130B
| $3.81B | 0.77% |
70,203,814
+8,675,322
| +14% | +$442M |
|
32
Sempra
SRE
$56.2B
| $3.77B | 0.76% |
52,487,411
-2,427,063
| -4% | -$174M |
|
33
Danaher
DHR
$145B
| $3.77B | 0.76% |
15,083,818
-872,701
| -5% | -$213M |
|
34
Equifax
EFX
$21.2B
| $3.76B | 0.76% |
14,045,398
+342,170
| +2% | +$87.1M |
|
35
Wells Fargo
WFC
$269B
| $3.44B | 0.7% |
59,374,633
-5,572,278
| -9% | -$292M |
|
36
CME Group
CME
$94.3B
| $3.4B | 0.69% |
15,809,175
+3,069,806
| +24% | +$645M |
|
37
KLA
KLAC
$272B
| $3.28B | 0.66% |
46,930,670
-1,979,120
| -4% | -$127M |
|
38
Dollar General
DG
$26.4B
| $3.24B | 0.66% |
20,790,023
+2,113,485
| +11% | +$300M |
|
39
ASML
ASML
$695B
| $3.23B | 0.65% |
3,327,529
-108,461
| -3% | -$96.2M |
|
40
ExxonMobil
XOM
$657B
| $3.2B | 0.65% |
27,511,952
+5,523,429
| +25% | +$578M |
|
41
Constellation Brands
STZ
$22.9B
| $3.18B | 0.64% |
11,685,249
+3,304,709
| +39% | +$836M |
|
|
42
Charter Communications
CHTR
$17.9B
| $3.07B | 0.62% |
10,558,651
+3,685,451
| +54% | +$1.18B |
|
43
Strategy Inc
MSTR
$37.3B
| $3.05B | 0.62% |
17,915,640
+2,326,670
| +15% | +$212M |
|
44
CVS Health
CVS
$121B
| $3.02B | 0.61% |
37,917,923
+4,226,225
| +13% | +$323M |
|
45
Regeneron Pharmaceuticals
REGN
$82.2B
| $3.01B | 0.61% |
3,129,010
+213,038
| +7% | +$203M |
|
46
ServiceNow
NOW
$129B
| $2.8B | 0.57% |
18,388,250
-1,483,390
| -7% | -$225M |
|
47
Arthur J. Gallagher & Co
AJG
$65.5B
| $2.76B | 0.56% |
11,050,941
+727,325
| +7% | +$175M |
|
48
Welltower
WELL
$166B
| $2.73B | 0.55% |
29,236,326
+6,104,064
| +26% | +$553M |
|
|
49
Johnson & Johnson
JNJ
$629B
| $2.71B | 0.55% |
17,155,881
-11,829,795
| -41% | -$1.88B |
|
50
ConocoPhillips
COP
$153B
| $2.71B | 0.55% |
21,252,822
+1,856,085
| +10% | +$212M |
|
Similar funds
Capital International Investors's Q1 2024 Portfolio in Review
As of Q1 2024, Capital International Investors held 456 positions worth $494B, up 11% from $446B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital International Investors's Q1 2024 filing shows 19 new, 211 increased, 141 reduced and 24 closed positions. Its largest new stake was Flutter Entertainment: 2,568,079 shares worth $507M. The largest sale was Broadcom, an estimated $2.89B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Industrials.
- Capital International Investors's largest Q1 2024 buy was Flutter Entertainment: 2,568,079 shares worth $507M.
- Capital International Investors added most to Amgen in Q1 2024, an estimated $1.73B increase.
- Capital International Investors's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.89B.
- Capital International Investors fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $1.34B.
- Capital International Investors's ten largest holdings make up 30% of its $494B portfolio in Q1 2024.
- Capital International Investors opened 19 new positions and closed 24 in Q1 2024.
- Capital International Investors's portfolio value rose 11% quarter-over-quarter to $494B.
Based on Capital International Investors's 13F filing for Q1 2024, filed 14 May 2024.